A hospital can invest in advanced scanners and digital platforms yet still leave clinicians assembling the information they need by hand. Images, reports, medication lists, and observations may each be available, but connecting them takes time. For healthcare leaders facing pressure on staffing, access, and budgets, this creates an opportunity: invest in technology that makes existing information more useful at the point of care.
My work in cardiovascular medicine and technology development has shaped how I evaluate that opportunity. Two initiatives, Fusion CV and VPExam, approach it from different settings. Fusion CV focuses on integrating information within cardiac imaging, while VPExam brings structured examination data into virtual care. Both reflect my view that innovation earns its place by helping clinicians make informed decisions within a workable care process.
Making more of existing imaging
Nuclear stress imaging evaluates blood supply to the heart muscle. In hybrid SPECT/CT and PET/CT examinations, computed tomography also helps correct the nuclear images for the effects of overlying tissue. Depending on the acquisition and image quality, these CT images can reveal coronary calcification that adds context to the perfusion findings.1
Fusion CV is a development initiative exploring how artificial intelligence can help bring that information together. The aim is to assess coronary calcium from suitable CT images already acquired during nuclear studies and present relevant findings alongside perfusion information in a form physicians can review and report. This could make a single examination more informative without requiring an additional scan solely for that analysis.
A practical implementation should place those findings in the reporting workflow clinicians already use, with access to the underlying images. That allows the physician to judge whether a result is credible and decide how it belongs in the final interpretation.
The distinction between potential and demonstrated performance matters. CT acquired for attenuation correction is not automatically equivalent to a dedicated, ECG-gated calcium-scoring study. Image quality, acquisition settings, and patient motion affect what can be measured reliably. Fusion CV therefore needs validation against appropriate references, explicit quality limits, and reporting that communicates uncertainty.2
For a hospital, the business question is whether this approach improves the usefulness of an examination enough to justify implementation. More consistent reporting and less manual assembly of information are reasonable objectives to test. Claims about fewer downstream tests, lower costs, or better outcomes require separate evidence.
Extending the clinical examination
VPExam addresses a related information gap outside the imaging laboratory. A patient recovering at home or in a skilled nursing facility may need cardiovascular assessment, yet a conventional video conversation can leave important examination findings unavailable to the remote clinician.
As founder of VPExam, I have focused on making those findings accessible through a structured virtual examination. The platform combines augmented reality guidance for image capture with connected tools, including digital stethoscopes and single-lead electrocardiography, alongside information such as vital signs and medication records. The purpose is to give clinicians a more useful picture of the patient between visits.3
The operational questions are as important as the devices. Someone must collect usable information, review it promptly, and arrange appropriate follow-up. A virtual examination also needs clear limits and a reliable route to in-person evaluation when the clinical situation requires it.
Building a business case around implementation
These examples shape my approach to emerging technology in healthcare. Before purchasing a platform, leaders should identify the exact task it will change. For an imaging service, that might be preparing a report or reviewing an additional finding. For virtual care, it might be assessing a recently discharged patient who would otherwise struggle to attend an appointment.
The evaluation should include the people doing that work. Physicians, nurses, technologists, and patients can identify burdens that a product demonstration misses. Additional logins, repeated data entry, unclear responsibilities, and unreliable equipment can consume the time a new system was intended to save.
Financial evaluation should follow the same discipline. License fees are only part of the cost. Integration, training, staff coverage, support, and ongoing quality review belong in the budget. A pilot should establish baseline performance and measure changes in clinician time, report completeness, follow-up timeliness, and other outcomes relevant to the intended use. Avoided admissions or testing should enter the return calculation only when the evidence supports attribution.
Trust also needs practical safeguards. Clinicians should be able to review the source information, recognize poor-quality inputs, and question an output. Organizations need defined responsibility for monitoring performance as equipment, software, and patient populations change.
Partnerships that support scale
For physician entrepreneurs, collaboration can determine whether a useful concept becomes a sustainable service. Health systems provide clinical settings and implementation experience. Academic collaborators contribute technical methods and study design. Industry partners bring engineering, distribution, and support capabilities. Each contribution should connect to a defined milestone, with success criteria agreed before the next investment.
That is the progression I envision for Fusion CV: establish technical reliability, evaluate its effect on clinical workflow, and build a commercial model around demonstrated value. VPExam reinforces the importance of carrying that thinking into everyday care delivery. Healthcare businesses should fund technologies that can explain whose work will improve, how that improvement will be measured, and what it will cost to sustain.





